$CL
Colgate-Palmolive Company
Global consumer products company with oral care, personal care, and home care brands.
CL key facts as of November 14, 2026
- Latest AI research report
- CL Stock Analysis: Valuation, Dividend and Outlook (as of November 14, 2026)
- StockAlpha report sentiment
- Neutral (as of November 14, 2026)
- Analyst consensus
- Strong Buy (6 Strong Buy, 7 Buy, 7 Hold, 0 Sell, 1 Strong Sell) (as of November 1, 2026)
- Analyst price target
- $101.30 mean (range $95.00 to $112.00) (as of November 20, 2026)
- Sector
- Consumer
Analysis from Nov 14, 2026
CL Stock Analysis: Valuation, Dividend and Outlook
Colgate-Palmolive’s defensive brands and cash generation support its steady profile, while a recent earnings beat adds a positive data point. At $99.67, however, the shares sit close to their 52-week high and the supplied analyst mean target, so valuation, margins and execution are key considerations.
Previous Reports
CL FAQ
What is StockAlpha's latest view on CL?
StockAlpha's latest AI research report on Colgate-Palmolive Company (CL), "CL Stock Analysis: Valuation, Dividend and Outlook", was published on November 14, 2026 and rates the overall sentiment as neutral. Colgate-Palmolive’s defensive brands and cash generation support its steady profile, while a recent earnings beat adds a positive data point. At $99.67, however, the shares sit close to their 52-week high and the supplied analyst mean target, so valuation, margins and execution are key considerations.
When was the CL research last updated?
The most recent CL report was published on November 14, 2026.
What do analysts expect for CL?
As of November 1, 2026, the analyst consensus on CL is Strong Buy (6 Strong Buy, 7 Buy, 7 Hold, 0 Sell, 1 Strong Sell). As of November 20, 2026, the analyst price target is $101.30 mean (range $95.00 to $112.00).
Is this CL research investment advice?
No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.
Keep exploring
- draft Colgate-Palmolive into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the consumer sector brief for context on Colgate-Palmolive's peers: Today's sector-level news and moves around the stock